Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
60 Degrees Pharmaceuticals has announced a 1:4 reverse stock split to comply with Nasdaq listing requirements. The split will become effective on January 20, 2026, and will affect all outstanding shares of common stock. The par value of the stock will remain unchanged at $0.0001 per share, and no fractional shares will be issued. The new CUSIP number for the stock will be 83006G500.

Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios